128 related articles for article (PubMed ID: 27058724)
1. Management of Noncommunicating Multiloculated Pleural Space Infection With Fibrinolytic Augmented Multiple Chest Tube Drainage.
Biswas A; Jantz MA; Barnes MD; Mehta HJ
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):e14-7. PubMed ID: 27058724
[No Abstract] [Full Text] [Related]
2. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
[TBL] [Abstract][Full Text] [Related]
3. Intrapleural fibrinolytics combined with image-guided chest tube drainage for pleural infection.
Levinson GM; Pennington DW
Mayo Clin Proc; 2007 Apr; 82(4):407-13. PubMed ID: 17418067
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
5. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
[TBL] [Abstract][Full Text] [Related]
6. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia.
Muhammad Redzwan SRA
Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections.
McClune JR; Wilshire CL; Gorden JA; Louie BE; Farviar AS; Stefanski MJ; Vallieres E; Aye RW; Gilbert CR
Can Respir J; 2016; 2016():9796768. PubMed ID: 27445574
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
[TBL] [Abstract][Full Text] [Related]
9. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and risks associated with intrapleural alteplase by means of tube thoracostomy.
Ben-Or S; Feins RH; Veeramachaneni NK; Haithcock BE
Ann Thorac Surg; 2011 Mar; 91(3):860-3; discussion 863-4. PubMed ID: 21353015
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural agents for pleural infection: fibrinolytics and beyond.
Rahman NM
Curr Opin Pulm Med; 2012 Jul; 18(4):326-32. PubMed ID: 22487944
[TBL] [Abstract][Full Text] [Related]
12. Intrapleural fibrinolytics for pleural infection: optimizing dosing for future trials.
Heppler JS
Mayo Clin Proc; 2007 Aug; 82(8):1016; author reply 1016-7. PubMed ID: 17673075
[No Abstract] [Full Text] [Related]
13. Breaking Down the Barriers in Complicated Pleural Sepsis.
Vorster MJ; Koegelenberg CF
Respiration; 2016; 91(2):99-100. PubMed ID: 26812401
[No Abstract] [Full Text] [Related]
14. Tissue plasminogen activator for mediastinal tube clearance in pediatric chylous effusion: A case report.
Delany DR; Newman JW; Atz AM
J Thorac Cardiovasc Surg; 2016 Sep; 152(3):e55-6. PubMed ID: 27236863
[No Abstract] [Full Text] [Related]
15. The paediatric chest tube.
Brandt ML; Luks FI; Lacroix J; Guay J; Collin PP; Dilorenzo M
Clin Intensive Care; 1994; 5(3):123-9. PubMed ID: 10150541
[TBL] [Abstract][Full Text] [Related]
16. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
[TBL] [Abstract][Full Text] [Related]
17. Portable chest drainage systems and outpatient chest tube management.
Varela G; Jiménez MF; Novoa N
Thorac Surg Clin; 2010 Aug; 20(3):421-6. PubMed ID: 20619234
[TBL] [Abstract][Full Text] [Related]
18. Management of parapneumonic effusions and empyema.
Psallidas I; Corcoran JP; Rahman NM
Semin Respir Crit Care Med; 2014 Dec; 35(6):715-22. PubMed ID: 25463162
[TBL] [Abstract][Full Text] [Related]
19. [Pleural drainage].
Klopp M; Hoffmann H; Dienemann H
Dtsch Med Wochenschr; 2009 Mar; 134(11):536-9. PubMed ID: 19235680
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage.
Gervais DA; Levis DA; Hahn PF; Uppot RN; Arellano RS; Mueller PR
Radiology; 2008 Mar; 246(3):956-63. PubMed ID: 18309017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]